CN103374759A - 一种检测肺癌转移标志性snp的方法及其应用 - Google Patents
一种检测肺癌转移标志性snp的方法及其应用 Download PDFInfo
- Publication number
- CN103374759A CN103374759A CN2012101269783A CN201210126978A CN103374759A CN 103374759 A CN103374759 A CN 103374759A CN 2012101269783 A CN2012101269783 A CN 2012101269783A CN 201210126978 A CN201210126978 A CN 201210126978A CN 103374759 A CN103374759 A CN 103374759A
- Authority
- CN
- China
- Prior art keywords
- gene
- nucleotide
- sudden change
- checking
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002773 nucleotide Substances 0.000 title claims abstract description 91
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 91
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 33
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 33
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title abstract description 40
- 206010027476 Metastases Diseases 0.000 title abstract description 26
- 230000009401 metastasis Effects 0.000 title abstract description 26
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 92
- 238000012163 sequencing technique Methods 0.000 claims abstract description 44
- 239000012634 fragment Substances 0.000 claims abstract description 25
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 10
- 230000008859 change Effects 0.000 claims description 68
- 230000000295 complement effect Effects 0.000 claims description 26
- 238000012360 testing method Methods 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 14
- 230000006287 biotinylation Effects 0.000 claims description 5
- 238000007413 biotinylation Methods 0.000 claims description 5
- 101150036441 F5 gene Proteins 0.000 claims description 4
- 101150091175 GTF3C1 gene Proteins 0.000 claims description 4
- 101100388113 Homo sapiens DEPTOR gene Proteins 0.000 claims description 4
- 101001057012 Homo sapiens Katanin-interacting protein Proteins 0.000 claims description 4
- 101000595534 Homo sapiens Transforming growth factor beta regulator 1 Proteins 0.000 claims description 4
- 101100489471 Homo sapiens ZNF641 gene Proteins 0.000 claims description 4
- 101150009427 MACC1 gene Proteins 0.000 claims description 4
- 101150058873 Map1a gene Proteins 0.000 claims description 4
- 101150115621 OR2T11 gene Proteins 0.000 claims description 4
- 101150043425 POP5 gene Proteins 0.000 claims description 4
- 101150060655 WNK1 gene Proteins 0.000 claims description 4
- 101150085482 ZNF641 gene Proteins 0.000 claims description 4
- 101150094684 ZNF717 gene Proteins 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 11
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 230000006806 disease prevention Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 71
- 239000000523 sample Substances 0.000 description 45
- 238000006243 chemical reaction Methods 0.000 description 43
- 239000011324 bead Substances 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 18
- 108090000790 Enzymes Proteins 0.000 description 18
- 230000008569 process Effects 0.000 description 16
- 206010028980 Neoplasm Diseases 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 238000013519 translation Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 7
- 102000004594 DNA Polymerase I Human genes 0.000 description 7
- 108010017826 DNA Polymerase I Proteins 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 102000012410 DNA Ligases Human genes 0.000 description 6
- 108010061982 DNA Ligases Proteins 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 238000005498 polishing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 238000001712 DNA sequencing Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 230000004853 protein function Effects 0.000 description 5
- 239000011535 reaction buffer Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 238000006062 fragmentation reaction Methods 0.000 description 4
- 108010055863 gene b exonuclease Proteins 0.000 description 4
- 238000007373 indentation Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 101150077807 SERPINB10 gene Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000009456 molecular mechanism Effects 0.000 description 2
- 230000000869 mutational effect Effects 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 101000832077 Xenopus laevis Dapper 1-A Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical class CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000005206 flow analysis Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SQMCFUSVGSBKFK-UHFFFAOYSA-M sodium;5-(cyclohexen-1-yl)-1,5-dimethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1N(C)C(=O)[N-]C(=O)C1(C)C1=CCCCC1 SQMCFUSVGSBKFK-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
样本 | 浓度(ng/μL) | 体积(μL) | A260/A280 | A260/A230 | 总量(μg) |
1 | 63.8 | 145 | 2.00 | 1.13 | 9.25 |
2 | 195.1 | 325 | 1.96 | 1.83 | 63.4 |
3 | 24.7 | 400 | 2.16 | 0.76 | 9.88 |
4 | 120.6 | 500 | 2.00 | 1.66 | 60.3 |
5 | 77.8 | 100 | 2.01 | 1.48 | 7.78 |
6 | 103.4 | 50 | 2.01 | 1.80 | 5.17 |
7 | 3.8 | 47 | 3.48 | 0.24 | 0.18 |
8 | 360.1 | 200 | 1.98 | 2.10 | 72.02 |
9 | 98.0 | 800 | 2.00 | 1.69 | 78.4 |
10 | 85.2 | 800 | 2.00 | 1.66 | 68.16 |
11 | 317.4 | 250 | 1.95 | 2.10 | 79.35 |
12 | 101.5 | 800 | 1.98 | 1.64 | 81.2 |
13 | 79.4 | 600 | 2.04 | 1.36 | 47.64 |
14 | 45.9 | 280 | 1.96 | 1.07 | 12.85 |
15 | 30.1 | 45 | 2.05 | 0.77 | 1.35 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210126978.3A CN103374759B (zh) | 2012-04-26 | 2012-04-26 | 一种检测肺癌转移标志性snp的方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210126978.3A CN103374759B (zh) | 2012-04-26 | 2012-04-26 | 一种检测肺癌转移标志性snp的方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103374759A true CN103374759A (zh) | 2013-10-30 |
CN103374759B CN103374759B (zh) | 2015-09-30 |
Family
ID=49460579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210126978.3A Active CN103374759B (zh) | 2012-04-26 | 2012-04-26 | 一种检测肺癌转移标志性snp的方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103374759B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105154444A (zh) * | 2015-10-15 | 2015-12-16 | 南京普东兴生物科技有限公司 | 一种有效提高建库效率的非对称高通量测序接头及其应用 |
CN106778072A (zh) * | 2016-12-30 | 2017-05-31 | 西安交通大学 | 针对第二代肿瘤基因组高通量测序数据的流程校正方法 |
CN107077538A (zh) * | 2014-12-10 | 2017-08-18 | 深圳华大基因研究院 | 测序数据处理装置和方法 |
CN109055547A (zh) * | 2018-09-30 | 2018-12-21 | 王赞鑫 | 一组评估主动脉夹层风险的生物标志物及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002103013A2 (en) * | 2000-10-30 | 2002-12-27 | Gene Logic, Inc. | Partially double-stranded nucleic acids, methods of making, and use thereof |
CN102016068A (zh) * | 2008-01-09 | 2011-04-13 | 生命科技公司 | 制备用于核酸测序的配对标签文库的方法 |
CN102373287A (zh) * | 2011-11-30 | 2012-03-14 | 盛司潼 | 一种检测肺癌易感基因的方法及试剂盒 |
WO2012037876A1 (zh) * | 2010-09-21 | 2012-03-29 | 深圳华大基因科技有限公司 | Dna标签及其应用 |
-
2012
- 2012-04-26 CN CN201210126978.3A patent/CN103374759B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002103013A2 (en) * | 2000-10-30 | 2002-12-27 | Gene Logic, Inc. | Partially double-stranded nucleic acids, methods of making, and use thereof |
CN102016068A (zh) * | 2008-01-09 | 2011-04-13 | 生命科技公司 | 制备用于核酸测序的配对标签文库的方法 |
WO2012037876A1 (zh) * | 2010-09-21 | 2012-03-29 | 深圳华大基因科技有限公司 | Dna标签及其应用 |
CN102409045A (zh) * | 2010-09-21 | 2012-04-11 | 深圳华大基因科技有限公司 | 一种基于dna接头连接的标签文库构建方法及其所使用标签和标签接头 |
CN102373287A (zh) * | 2011-11-30 | 2012-03-14 | 盛司潼 | 一种检测肺癌易感基因的方法及试剂盒 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107077538A (zh) * | 2014-12-10 | 2017-08-18 | 深圳华大基因研究院 | 测序数据处理装置和方法 |
CN107077538B (zh) * | 2014-12-10 | 2020-08-07 | 深圳华大生命科学研究院 | 测序数据处理装置和方法 |
CN105154444A (zh) * | 2015-10-15 | 2015-12-16 | 南京普东兴生物科技有限公司 | 一种有效提高建库效率的非对称高通量测序接头及其应用 |
CN106778072A (zh) * | 2016-12-30 | 2017-05-31 | 西安交通大学 | 针对第二代肿瘤基因组高通量测序数据的流程校正方法 |
CN106778072B (zh) * | 2016-12-30 | 2019-05-21 | 西安交通大学 | 针对第二代肿瘤基因组高通量测序数据的流程校正方法 |
CN109055547A (zh) * | 2018-09-30 | 2018-12-21 | 王赞鑫 | 一组评估主动脉夹层风险的生物标志物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103374759B (zh) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10515714B2 (en) | Methods for accurate sequence data and modified base position determination | |
EP3177740B1 (en) | Digital measurements from targeted sequencing | |
CN108138209B (zh) | 通过原位扩增制备细胞游离核酸分子的方法 | |
US9249460B2 (en) | Methods for obtaining a sequence | |
WO2020056381A9 (en) | PROGRAMMABLE RNA-TEMPLATED SEQUENCING BY LIGATION (rSBL) | |
KR20190132558A (ko) | 카피수 변이를 판정하기 위한 dna 단편 크기의 사용 | |
CN103060924A (zh) | 微量核酸样本的文库制备方法及其应用 | |
EP3607065B1 (en) | Method and kit for constructing nucleic acid library | |
CN104603287A (zh) | 用于测定核苷酸序列的方法 | |
CN101838683B (zh) | 一种kras基因和/或braf基因的核苷酸突变位点的检测方法 | |
EA035451B1 (ru) | Способ диагностики рака с использованием геномного секвенирования | |
US8192938B2 (en) | Methods for quantifying microRNA precursors | |
CN102181533A (zh) | 多样本混合测序方法及试剂盒 | |
Southard-Smith et al. | Dual indexed library design enables compatibility of in-Drop single-cell RNA-sequencing with exAMP chemistry sequencing platforms | |
CN110396534A (zh) | 基因文库的构建方法、待测核酸样本基因突变的检测方法及试剂盒 | |
CN106520917A (zh) | 一种基因的大片段缺失/重复检测的方法 | |
CN115135776A (zh) | 多重drop-off数字聚合酶链式反应方法 | |
CN103374759B (zh) | 一种检测肺癌转移标志性snp的方法及其应用 | |
CN102534042A (zh) | 一种多重竞争性pcr定量基因表达谱分析方法 | |
CN112342303A (zh) | 一种基于ngs的人类y染色体str和snp遗传标记联合检测体系及检测方法 | |
CN102782152A (zh) | Rna分析方法 | |
Wang et al. | Targeted sequencing of both DNA strands barcoded and captured individually by RNA probes to identify genome-wide ultra-rare mutations | |
CN108026532A (zh) | 新型mirna生物标志物及其用途 | |
Persson et al. | Preparation of highly multiplexed small RNA sequencing libraries | |
Chen et al. | Expression profile and bioinformatics analysis of circular RNAs in tongue squamous cell carcinoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190808 Address after: 250101 Shandong Province Jinan Hi-tech Zone Comprehensive Bonded Zone No. 1 North Section of Gangxing No. 3 Road Jinan Yaogu R&D Platform Area No. 2 Building 2508 Co-patentee after: Shandong Yuexin Inspection and Certification Group Co.,Ltd. Patentee after: JINAN MEASUREMENT METERING RESEARCH INSTITUTE Co.,Ltd. Co-patentee after: Shandong Yue Pin Education Group Co.,Ltd. Address before: 200031 Yueyang Road, Shanghai, No. 319, No. Patentee before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 2508, building 2, Jinan pharmaceutical Valley R & D platform area, No.1, north section of Gangxing Third Road, Jinan City, Shandong Province Patentee after: Measurement Research Institute (Shandong) Group Co.,Ltd. Patentee after: Institute of food, drug and environmental control (Shandong) Group Co.,Ltd. Patentee after: Academy of food, drug and Environmental Sciences (Shandong) Group Co.,Ltd. Address before: 250101 Shandong Province Jinan Hi-tech Zone Comprehensive Bonded Zone No. 1 North Section of Gangxing No. 3 Road Jinan Yaogu R&D Platform Area No. 2 Building 2508 Patentee before: JINAN MEASUREMENT METERING RESEARCH INSTITUTE Co.,Ltd. Patentee before: Shandong Yuexin Inspection and Certification Group Co.,Ltd. Patentee before: Shandong Yue Pin Education Group Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240102 Address after: 250100, Building 2, Jinan Pharmaceutical Valley R&D Platform Area, No. 1, North Section of Gangxing Third Road, Jinan Area, China (Shandong) Pilot Free Trade Zone, Jinan City, Shandong Province, China 2508 Patentee after: Measurement Research Institute (Shandong) Group Co.,Ltd. Address before: 2508, building 2, Jinan pharmaceutical Valley R & D platform area, No. 1, north section of Gangxing Third Road, Jinan City, Shandong Province Patentee before: Measurement Research Institute (Shandong) Group Co.,Ltd. Patentee before: Institute of food, drug and environmental control (Shandong) Group Co.,Ltd. Patentee before: Academy of food, drug and Environmental Sciences (Shandong) Group Co.,Ltd. |
|
TR01 | Transfer of patent right |